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W aitlist management is an ongoing challenge for pub-licly funded health care systems because available resources are finite. This challenge has become more 
pervasive since the onset of the COVID-19 pandemic, as many 
nonemergent procedures have been postponed to preserve sys-
tem capacity for patients with COVID-19.1
The decision to triage patients booked for cardiac surgery bal-
ances the likelihood of disease decompensation and the avail-
ability of operating room and intensive care unit resources. Our 
group has previously developed and validated the CardiOttawa 
Length of Stay Score to estimate the likelihood of high or low 
needs for postoperative intensive care unit resources,2 and the 
CardiOttawa Waitlist Mortality Score to support evidence-based 
prioritization for cardiac surgeries. These risk models have been 
combined into a single triage decision support tool that is used 
on a daily basis at our institution (available with sign up at 
https://cardiottawa.ottawaheart.ca). No models are available to 
predict unplanned hospitalizations for patients on the waitlist for 
definitive surgical interventions. We therefore conducted a 
 population-based study in Ontario, Canada to derive and vali-
date a clinical model to predict the composite outcome of death 
or unplanned cardiac hospitalizations in patients on the waitlist 
for cardiac surgery.
Methods
Study design and population
We conducted a population-based, retrospective cohort study of 
adult patients 18 years or older who were on the waitlist for aor-
tic, mitral or tricuspid valve surgery, coronary artery bypass 
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Abstract
Background: Waitlist management is a 
global challenge. For patients with 
severe cardiovascular diseases awaiting 
cardiac surgery, prolonged wait times 
are associated with unplanned hospital-
izations. To facilitate evidence-based 
resource allocation, we derived and vali-
dated a clinical risk model to predict the 
composite outcome of death and car-
diac hospitalization of patients on the 
waitlist for cardiac surgery.
Methods:  We used the CorHealth 
Ontario Registry and linked ICES health 
care administrative databases, which 
have information on all Ontario resi-
dents. We included patients 18 years or 
older who waited at home for coronary 
artery bypass grafting, valvular or thor-
acic aorta surgeries between 2008 and 
2019. The primary outcome was death 
or an unplanned cardiac hospitalizaton, 
defined as nonelective admission for 
heart failure, myocardial infarction, 
unstable angina or endocarditis. We 
randomly divided two-thirds of these 
patients into derivation and one-third 
into validation data sets. We derived the 
model using a multivariable Cox propor-
tional hazard model with backward 
stepwise variable selection.
Results: Among 62 375 patients, 41 729 
patients were part of the derivation data 
set and 20 583 were part of the valida-
tion data set. Of the total, 3033 (4.9%) 
died or had an unplanned cardiac hospi-
talization while waiting for surgery. The 
area under the curve of our model at 15, 
30, 60 and 89 days was 0.85, 0.82, 0.81 
and 0.80, respectively, in the derivation 
cohort and 0.83, 0.80, 0.78 and 0.78, 
respctively, in the validation cohort. The 
model calibrated well at all time points.
Interpretation: We derived and vali-
dated a clinical risk model that pro-
vides accurate prediction of the risk of 
death and unplanned cardiac hospital-
ization for patients on the cardiac sur-
gery waitlist. Our model could be used 
for quality benchmarking and data-
driven decision support for managing 
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grafting (CABG) or surgery on the thoracic aorta in Ontario 
between Oct. 1, 2008, and Sept. 30, 2019. We restricted our study 
to patients who waited for surgery at home, and excluded those 
who were accepted to and removed from the waitlist on the 
same date.
Data source
We used the clinical registry of CorHealth Ontario and 
 population-level administrative health care databases from 
ICES. ICES holds multiple population-based health databases of 
Ontario residents. CorHealth Ontario maintains a prospective 
registry of all patients who receive invasive cardiac procedures 
in Ontario; the data undergo selected chart audits and core lab-
oratory validation.3
Using unique confidential identifiers, we deterministically 
linked the following data sets and analyzed them at ICES: the 
CorHealth Ontario registry (for detailed cardiac surgery waitlist 
data, operative priority, date and type of cardiac procedures, and 
physiologic and comorbidity data), the Canadian Institute for 
Health Information Discharge Abstract Database (for comorbidi-
ties, hospital admissions and in-hospital procedures), the 
Ontario Health Insurance Plan database (for physician service 
claims) and the Registered Persons Database (for vital statistics). 
These administrative databases have been validated for many 
outcomes, exposures and comorbidities, including heart failure, 
chronic obstructive pulmonary disease, asthma, hypertension, 
and diabetes.4–7 Ontario is the most populous province in Can-
ada, with about 14.6 million residents, and is ethnically diverse.
Potential covariates included demographic, physiologic, ana-
tomic and comorbidity data, as well as information about the 
planned procedure (i.e., operative priority status, recommended 
surgical wait time, redo sternotomy, type of surgery and accep-
tance to the waitlist during an inpatient encounter). We obtained 
data on height, weight and operative priority, and information 
pertaining to left ventricular ejection fraction, valvular disease 
and coronary anatomy from the CorHealth Ontario registry. In 
addition, we identified comorbidities from the CorHealth Ontario 
registry, which we supplemented with data from the Discharge 
Abstract Database and the Ontario Health Insurance Plan data-
base using International Classification of Diseases and Related 
Health Problems, 10th Revision (ICD-10-CA) codes8 within 5 years 
before waitlist entry, according to validated algorithms.4,6,9,10
Outcome
The primary outcome was the composite of death or unplanned 
cardiac hospitalization, defined as nonelective admission for 
heart failure, myocardial infarction, unstable angina or endo-
card itis between the dates of waitlist entry and removal.
Statistical analysis
We compared the baseline characteristics of patients who died or 
had an unplanned cardiac hospitalization while on the waitlist with 
those of patients without these outcomes. We compared continuous 
variables with a 2-sample Student t test or Wilcoxon rank sum test, 
where appropriate, and categorical variables with a χ2 test. We fol-
lowed patients from the date of entry to the waitlist until surgery or 
loss of eligibility for the Ontario Health Insurance Plan, whichever 
occurred first. We removed patients from the waitlist when they died 
or underwent their planned cardiac surgery.
We imputed missing values once using the SAS “proc MI” 
framework, where they were predicted by drawing on all candi-
date covariates, using predictive mean matching for continuous 
variables and logistic regression for categorical variables.11
We split the cohort into derivation and validation data sets by 
random selection, such that two-thirds of the cohort was used to 
derive the model.12 We predicted death or unplanned cardiac 
hospitalization using a Cox proportional hazard model.13 We 
selected predictor variables using a backward stepwise algo-
rithm, with a significance threshold of p  <  0.1 for entry and 
p < 0.05 for retention in the model.14 For continuous variables, we 
examined their association with the composite outcome using 
cubic spline analyses, with 5 knots at percentiles 5, 27.5, 50, 72.5 
and 95. As there was no violation of the linearity assumption for 
any of these variables, we entered them into the model as con-
tinuous values. We validated the model on the remaining one-
third of the cohort.
In both derivation and validation cohorts, we evaluated 
model discrimination in a time-dependent fashion using the 
area under the receiver-operating characteristic curve (AUC) at 
15, 30, 60 and 89 days. We assessed calibration using the Brier 
score,15 as well as time-dependent plots of observed versus pre-
dicted mortality rates within vigintiles of predicted risk in the 
validation cohort.
We performed the analysis using SAS 9.4 (SAS Institute, Cary, NC) 
and defined statistical significance by a 2-sided p value of < 0.05.
Ethics approval
The use of data was authorized under section 45 of Ontario’s Per-
sonal Health Information Protection Act, which does not require 
review by a research ethics board.3
Results
Among 62 375 patients, 3033 (4.9%) died or were nonelectively 
hospitalized for cardiac causes while on the waitlist. These 
events occurred in 2091 (6.4%) of all 32 572 patients awaiting iso-
lated CABG, 500 (2.6%) of 19 281 patients awaiting valve proced-
ures, 415 (5.2%) of 7933 patients awaiting combined CABG and 
valve procedures, and 27 (1.0%) of 2589 patients awaiting thor-
acic aorta procedures. The characteristics of patients who did or 
did not have an event are presented in Table 1.  
The median time from waitlist entry to the composite out-
come was 33 (interquartile range [IQR] 16–57) days in all 
patients, and 27 (IQR 13–48) days for patients waiting for CABG, 
41 (IQR 22–71) days for patients waiting for valve surgery, 35 (IQR 
20–59) days for patients waiting for combined CABG and valve 
surgery, and 46 (IQR 27–75) days for patients waiting for thoracic 
aorta procedures.
Of 41 792 patients in the derivation cohort, 2035 (4.9%) died 
or had unplanned cardiac hospitalizations while awaiting sur-
gery. Of 20 583 patients in the validation cohort, 998 (4.8%) had 
an event while on the waitlist. 
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Table 1 (part 1 of 2): Baseline characteristics of patients who died or had unplanned cardiac hospitalizations 
while on the waitlist for cardiac surgery, compared with those who did not
Variable






n = 59 342
Demographics
Age, yr, mean ± SD 67.1 ± 10.3 66.3 ± 10.9 0.07
Age, yr, median (IQR) 68 (60–74) 67 (60–74) 0.05
Sex, female 756 (24.9) 15 626 (26.3) 0.03
BMI, kg/m2, mean ± SD, 28.56 ± 5.38 28.95 ± 5.56 0.07
BMI, kg/m2, median (IQR) 28 (25–31) 28 (25–32) 0.07
Rural residence 2619 (86.4) 50 619 (85.3) 0.03
Hospital type
    Community 379 (12.5) 14 953 (25.2) 0.33
    Teaching 2654 (87.5) 44 389 (74.8)
Waitlisted during inpatient encounter 770 (25.4) 2913 (4.9) 0.6
Comorbidities
Hypertension 2662 (87.8) 49 488 (83.4) 0.12
Atrial fibrillation 418 (13.8) 7212 (12.2) 0.05
Recent myocardial infarction 437 (14.4) 2119 (3.6) 0.39
CCS classification
    0 575 (19.0) 21 386 (36.0) 0.39
    1 483 (15.9) 8805 (14.8) 0.03
    2 569 (18.8) 14 989 (25.3) 0.16
    3 603 (19.9) 11 828 (19.9) 0
    4 163 (5.4) 1112 (1.9) 0.19
    Low-risk acute coronary syndrome 360 (11.9) 858 (1.4) 0.43
    Intermediate-risk acute coronary syndrome 260 (8.6) 339 (0.6) 0.39
    High-risk acute coronary syndrome 20 (0.7) 25 (0.0) 0.1
Left main or left main equivalent disease 1311 (43.2) 18 319 (30.9) 0.26
Proximal LAD artery disease 1346 (44.4) 19 571 (33.0) 0.24
Previous percutaneous coronary intervention 375 (12.4) 6047 (10.2) 0.07
Left ventricular ejection fraction, %
    ≥ 50 2108 (69.5) 46 417 (78.2) 0.2
    35–49 611 (20.1) 9367 (15.8) 0.11
    20–35 273 (9.0) 3057 (5.2) 0.15
    < 20 41 (1.4) 501 (0.8) 0.05
NYHA classification
    1 2038 (67.2) 35 438 (59.7) 0.16
    2 409 (13.5) 12 920 (21.8) 0.22
    3 460 (15.2) 10 251 (17.3) 0.06
    4 126 (4.2) 733 (1.2) 0.18
Heart failure 968 (31.9) 13 843 (23.3) 0.19
Moderate-severe mitral regurgitation 220 (7.3) 6951 (11.7) 0.15
Moderate-severe aortic regurgitation 69 (2.3) 2278 (3.8) 0.09
Severe aortic stenosis 687 (22.7) 18 980 (32.0) 0.21
Endocarditis
    None 3007 (99.1) 58 852 (99.2) 0
    Acute 13 (0.4) 154 (0.3) 0.03
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Table 1 (part 2 of 2): Baseline characteristics of patients who died or had unplanned cardiac hospitalizations 
while on the waitlist for cardiac surgery, compared with those who did not
Variable






n = 59 342
Cerebrovascular disease 314 (10.4) 5451 (9.2) 0.04
Peripheral arterial disease 412 (13.6) 7942 (13.4) 0.01
Smoking status
    Never 1448 (47.7) 29 074 (49.0) 0.03
    Current 604 (19.9) 9129 (15.4) 0.12
    Former 981 (32.3) 21 139 (35.6) 0.07
Chronic obstructive pulmonary disease 795 (26.2) 13 111 (22.1) 0.1
Diabetes 1435 (47.3) 23 204 (39.1) 0.17
Dyslipidemia 2116 (69.8) 39 600 (66.7) 0.07
GFR, mL/min/1.73 m2, mean ± SD 82.0 ± 35.2 86.2 ± 34.1 0.12
GFR, mL/min/1.73 m2, median (IQR) 79 (58–103) 82 (62–105) 0.11
Dialysis 90 (3.0) 1074 (1.8) 0.08
Anemia 197 (6.5) 2344 (3.9) 0.11
Liver disease 37 (1.2) 561 (0.9) 0.03
Alcohol abuse 43 (1.4) 509 (0.9) 0.05
Dementia 47 (1.5) 656 (1.1) 0.04
Depression 51 (1.7) 415 (0.7) 0.09
Psychosis 6 (0.2) 70 (0.1) 0.02
Primary cancer 150 (4.9) 2887 (4.9) 0
Metastatic cancer 18 (0.6) 287 (0.5) 0.02
Operative characteristics
Surgery type
    CABG 2091 (68.9) 30 481 (51.4) 0.36
    Valve 500 (16.5) 18 781 (31.6) 0.36
    CABG + valve 415 (13.7) 7518 (12.7) 0.03
    Thoracic vorta 27 (0.9) 2562 (4.3) 0.22
Redo sternotomy 131 (4.3) 2047 (3.4) 0.05
Cardiogenic shock 1–5† 56 (0.1) 0.01
Operative priority
    Urgent 988 (32.6) 20 296 (34.2) 0.03
    Semiurgent 844 (27.8) 11 180 (18.8) 0.21
    Elective 1201 (39.6) 27 866 (47.0) 0.15
Wait time characteristics
Recommend maximum wait time, d, mean ± SD 41.3 ± 31.0 43.7 ± 34.2 0.07
Recommend maximum wait time, d, median (IQR) 31 (14–62) 40 (14–71) 0.05
Adherence to recommended wait time‡ 1999 (65.9) 31 126 (52.5) 0.28
All-cause ED visits while on the waitlist, mean ± SD 0.3 ± 0.6 0.1 ± 0.5 0.28
All-cause ED visits while on the waitlist, median (IQR) 0 (0–0) 0 (0–0) 0.35
All-cause outpatient physician visits while on the waitlist, 
mean ± SD
1.0 (1.5) 2.1 (1.8) 0.63
All-cause outpatient physician visits while on the waitlist, 
median (IQR)
1 (0–2) 2 (1–3) 0.75
Note: BMI = body mass index, CABG = coronary artery bypass grafting, CCS = Canadian Cardiovascular Society, ED = emergency department, GFR = glomerular 
filtration rate, IQR = interquartile range, LAD = left anterior descending, NYHA = New York Heart Association, SD = standard deviation.
*Unless indicated otherwise.
†Data suppressed because of small cell size.
‡Adherence is defined as adhering to the procedure-specific wait times recommended by the Canadian Cardiovascular Society Access to Care Working Group.1
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Predictors of death or unplanned cardiac 
hospitalization on the waitlist
The final predictive model, based on the derivation cohort, con-
sisted of 16 variables (Table 2): body mass index, entry to the 
waitlist during an inpatient encounter, urban residence, treat-
ment at a teaching hospital, myocardial infarction within 
30 days, Canadian Cardiovascular Society and New York Heart 
Association classifications, history of heart failure, atrial fibril-
lation, diabetes, glomerular filtration rate, proximal left 
an terior descending artery disease, aortic stenosis, endocard-
itis, operative priority at the time of waitlist entry and type of 
planned surgery.
Model performance
In the derivation cohort, the AUCs of the model were 0.85, 
0.82, 0.81 and 0.80 at 15, 30, 60 and 89 days, respectively. In 
the validation cohort, the AUCs were 0.83, 0.80, 0.78 and 0.78 
(Figure 1), and the Brier Scores were 0.027, 0.037, 0.05, and 
0.06 at 15, 30, 60 and 89 days, respectively. Figure 2 shows the 
calibration plots of observed and predicted deaths or 
unplanned cardiac hospitalizations on the waitlist, according 
to vigintiles of risk at each of the 4 time points. The observed 
and predicted numbers of events in the validation cohort 
were similar across all patients except among those in the 
highest probability vigintiles, where the predicted risk under-
estimated the likelihood of events in the 4 highest risk vigin-
tiles at 15 and 30 days, overestimated the likelihood of events 
in the top vigintile at 60 and 89 days. The model has been 
coded into an online application (available with sign up at 
https://cardiottawa.ottawaheart.ca/).
Characteristics of patients at high risk of death or 
unplanned cardiac hospitalization
As the risk of death or cardiac hospitalization was particularly 
high in the 2 highest probability vigintiles, we conducted a post 
hoc analysis to examine the baseline characteristics of these 
high-risk patients compared with other patients in the validation 
cohort (Appendix 1, Supplemental Table 1, available at www.
cmaj.ca/lookup/doi/10.1503/cmaj.210170/tab-related-content). 
Patients who were male, were urban dwellers, were treated at 
teaching hospitals, had more severe cardiac symptoms (i.e., 
higher CCS and NYHA classifications), were scheduled to 
undergo CABG surgery, had proximal left anterior descending 
artery or left main stem coronary artery stenosis, had reduced 
left ventricular ejection fraction, had reduced renal function or 
had a higher comorbidity burden, were more likely to be at high-
est risk of death or cardiac hospitalization.
Discussion
We have provided an algorithm for predicting accurate, time-
dependent risk estimates of the composite outcome of death 
and unplanned cardiac hospitalizations while on the waitlist, 
derived from and externally validated on a large and ethnically 
diverse population. The variables included in our model are 
readily available at the time of referral for surgery. 
Table 2: Multivariable predictors of patient death or 
unplanned cardiac hospitalization while on the waitlist 
for cardiac surgery
Variable HR (95% CI) p value
Demographics
BMI 0.99 (0.98–1.00) 0.004
Teaching v. community hospital 1.79 (1.56–2.05) < 0.001
Waitlisted during inpatient encounter 5.05 (4.48–5.70) < 0.001
Rural residence 0.86 (0.75–0.97) 0.02
Comorbidities
CCS classification
    0 Reference
    1 1.59 (1.36–1.87) < 0.001
    2 1.20 (1.02–1.40) 0.03
    3 1.49 (1.27–1.75) < 0.001
    4 2.74 (2.18–3.45) < 0.001
    Low-risk acute coronary syndrome 6.01 (4.96–7.29) < 0.001
    Intermediate-risk acute coronary  
    syndrome
8.37 (6.68–10.49) < 0.001
    High-risk acute coronary syndrome 8.08 (4.81–13.56) < 0.001
Recent myocardial infarction 0.84 (0.72–0.97) 0.02
NYHA classification
    1 Reference
    2 0.72 (0.62–0.84) < 0.001
    3 0.94 (0.8–1.09) 0.4
    4 1.78 (1.4–2.26) < 0.001
Heart failure 1.4 (1.25–1.56) < 0.0001
Atrial fibrillation 1.26 (1.1–1.44) 0.0007
Diabetes 1.13 (1.03–1.24) 0.008
GFR, per 10 unit increase 0.98 (0.96–0.99) 0.003
Proximal LAD > 70% stenosis 1.11 (1.01–1.23) 0.03
Severe aortic stenosis 1.28 (1.08–1.52) 0.004
Endocarditis
    None Reference
    Acute 2.17 (1.16–4.08) 0.02
    Subacute 0.79 (0.37–1.66) 0.5
Operative characteristics
Surgery type
    CABG Reference
    Valve 0.33 (0.27–0.41) < 0.001
    CABG + valve 0.61 (0.49–0.76) < 0.001
    Thoracic aorta 0.16 (0.1–0.27) < 0.001
Operative priority
    Urgent 1.45 (1.24–1.69) < 0.001
    Semiurgent 1.50 (1.34–1.68) < 0.001
    Elective Reference
Note: BMI = body mass index, CABG = coronary artery bypass grafting, CCS = Canadian 
Cardiovascular Society, CI = confidence interval, GFR = glomerular filtration rate,  
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Waitlist management is challenging in publicly funded health 
care systems. Prolonged wait times may lead to increased deaths, 
hospitalizations and procedure urgency while patients await their 
surgery,16 as well as greater postoperative mortality, morbidity 
and disability rates.17,18 Existing guidance for waitlist management 
for cardiac surgery are based on expert opinion, as few real-world 
data are available to inform evidence-based decision-making.19,20
To date, efforts to risk stratify patients on the waitlist have 
been limited by small data sets, mainly in patients waiting for 
CABG and heart transplantation.21–25 The only contemporary, 
population-based study that included most cardiac surgeries 
evaluated mortality rates and did not address other important 
complications while on the waitlist.19 Given the medical complex-
ity of these patients and the risk of decompensation while wait-
ing, a data-driven approach is needed to individualize wait times 
and facilitate safe and timely triaging.
We developed this waitlist model to prioritize high-risk 
patients needing definitive surgery, improve patient outcomes 































































Figure 2: Calibration plots of observed (dots) versus predicted (dashed line) death or cardiac hospitalization on the waitlist at (A) 15, (B) 30, (C) 60 and 
(D) 90 days, according to vigintiles of risk.


















Area under the curve95% CI
Figure 1: Continuous plot of area under the receiver-operating character-
istic curve values against time, with 95% confidence interval (CI).
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and reduce use of health care resources. Our model can be used 
to provide decision support for referring physicians and the 
 surgery–anesthesiology team, as well as health care administra-
tors, through time-dependent, individualized risk prediction. It 
could also be used in quality benchmarking and to compare 
wait-time metrics across centres. In addition, we have identified 
features of patients who are at the highest risk of death or 
unplanned cardiac hospitalization while on the waitlist, which 
could be used to identify those who are most likely to benefit 
from expedited surgery.
Although little literature exists on death and unplanned car-
diac hospitalization while on the waitlist for cardiac surgery, the 
risk factors identified from our model are similar to those from 
other studies of death while on the waitlist. In a 2017 systematic 
review, Head and colleagues identified angiographic complexity, 
angina severity, symptoms on stress testing and left ventricular 
dysfunction as risk factors for death while on the CABG waitlist.25 
In a population-based study of the cardiac surgery waitlist in 
Alberta, Canada, Senaratne and colleagues identified age, aortic 
surgery, reduced left ventricular ejection fraction, urgent surgery, 
prior myocardial infarction, hemodynamic instability during 
 cardiac catheterization, hypertension and dyslipidemia as 
independ ent risk factors for death.19 The differences in risk 
 factors between this and our study likely reflect our use of a com-
posite end point instead of death alone, as well as differences in 
patient inclusion criteria. Specifically, Senaratne included 
patients awaiting emergent surgery and those awaiting their pro-
cedures as inpatients, whereas we excluded these patients from 
our study.
Current guidance on waitlist management is based primarily 
on anatomic factors, such as coronary and valvular disease. Our 
predictor variables include anatomic factors, patient comorbidi-
ties, severity of cardiac symptoms, patient demographics, hospi-
tal characteristics, as well as characteristics of the proposed pro-
cedure. Adherence to the Canadian Cardiovascular Society’s 
recommended wait times for cardiac procedures may be insuffi-
cient to ensure patient safety,19 whereas our model has the 
potential to reduce adverse outcomes and use of health care 
resources through accurate, individualized risk stratification. It 
could be combined with the CardiOttawa Length of Stay Score2 
(available with sign up at https://cardiottawa.ottawaheart.ca) to 
personalize wait times and optimize capacity in the intensive 
care unit. Like all decision-support tools, these models are 
intended to assist clinicians and should be used along with clin-
ical judgment when making decisions.
Limitations
We were unable to include information about medical therapy 
because publicly funded drug coverage is available only to 
Ontario residents 65 years and older. However, model per-
formance was excellent based on information that is available. 
Some physiologic measures, such as brain natriuretic peptide, 
were not available in the databases we used. However, brain 
natriuretic peptide is not routinely measured in the perioperative 
setting and the inclusion of such parameters might have limited 
the applicability of the model. We were unable to determine the 
cause of death on the waitlist, but it is likely that most deaths 
were from cardiac causes. We limited our model to commonly 
performed cardiac surgeries and it may not perform similarly in 
different patients, such as those waiting for heart transplantation 
or ventricular assist devices. 
Conclusion
Our model accurately predicts the risk of death or unplanned 
cardiac hospitalization in patients on the waitlist for cardiac sur-
gery. The model performed well in a large population-based 
sample. It can be combined with the CardiOttawa Length of Stay 
tool to benchmark quality and performance across centres, as 
well as provide triage decision support for clinicians, hospital 
administrators and policy-makers to improve access to cardiac 
care and conserve system capacity. This model should be evalu-
ated in other health care jurisdictions.
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